Biotech

All Articles

James Wilson leaving behind Penn to launch pair of brand-new biotechs

.After greater than three decades, gene treatment trendsetter James Wilson M.D., Ph.D., is actually ...

3 biotechs try to trump the summer season heat by losing workers

.As biotechs seek to transform a fresh page in August, a minimum of three companies have actually lo...

venBio elevates $528M for fifth lifestyle sciences VC fund

.Professional equity capital agency venBio has lifted another half a billion dollars to invest in bi...

Otsuka pays for $800M for Jnana and also its clinical-stage PKU medicine

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapies for $800 million so the Japanese bio...

FibroGen gives up 75% of US team as property fails 2 more trials

.FibroGen is actually substantially reorganizing its own service, giving up 75% of its own U.S. work...

Tracon winds down full weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually determined to unwind functions full weeks after an injectable i...

Ideaya bags choice on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M loss on neglected epilepsy medication, boasts FDA run

.We currently recognize that Takeda is intending to locate a road to the FDA for epilepsy medicine s...

VBI Vaccines apply for bankruptcy, looks for asset sale

.Immunology biotech VBI Injections is actually turning hazardously near to the defining moment, alon...

Celldex anti-cKIT antibody decrease hives in another stage 2 research

.It's challenging to muscular tissue in on a space as very competitive as immunology, but Celldex Re...